ArticleScientific reports2025
Epidemiology and risk factors of glaucoma in a comprehensive health screening baseline report from the Gangnam Eye Cohort Study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Association between alcohol and tobacco use and primary open-angle glaucoma: the Eyes of Africa study.Eye and vision (London, England) · 2026Article
- Retinal Arteriosclerosis and Fundus Photograph-Defined Glaucoma in Young Adults: Findings from the Gangnam Eye Cohort.Biomedicines · 2026Article
- Association of the ACE2 rs879922 Polymorphism with Glaucoma Risk and Serum ACE2 Levels.Journal of clinical medicine · 2026Article
- Sectoral Analysis of Corneal Thickness in Glaucoma and Healthy Eyes and Its Relationship with RNFL and Rim Area.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
We investigated the epidemiology and systemic risk factors of glaucoma in a health screening center-based cohort. The Gangnam Eye Cohort Study included 75,154 participants who completed initial comprehensive health check-up examinations in 2003-2010. In this baseline report, the prevalence of glaucoma was estimated, ocular and systemic factors were compared between glaucoma and normal control groups, and risk factors were analyzed by logistic regression. The prevalence of glaucoma was 2.8%; 3.4% in men and 2.1% in women, and increased with age (P < 0.001). Mean age of the glaucoma group (52.8 ± 10.9 years) was older than that of the normal group (48.1 ± 10.3 years, P < 0.001). Mean intraocular pressure (IOP) of the glaucoma group (14.6 ± 3.1 mmHg) was higher than that of the normal group (13.2 ± 2.5 mmHg, P < 0.001). Older age (P < 0.001), male sex (P < 0.001), presence of retinal arteriosclerosis (P < 0.001), higher IOP (P < 0.001), higher household income (P = 0.045), higher education (P < 0.001), overweight status (P = 0.001), higher serum creatinine (P = 0.013) and uric acid (P = 0.008) were significantly associated with glaucoma. In this largest health screening center-based cohort study, considering the associations of glaucoma with retinal microvascular abnormality, obesity, and serum creatinine and uric acid, a common pathway such as arteriosclerosis or oxidative stress may be the vascular problem underlying glaucoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.